Skip to main content
Bruce Bochner, MD, Allergy & Immunology, Chicago, IL

Bruce S Bochner MD

Asthma & Allergic Conditions


Professor, Medicine, Northwestern University

Join to View Full Profile
  • 680 N Lake Shore DrSte 1000Chicago, IL 60611

  • Phone+1 312-695-9797

  • Fax+1 312-695-6070

Dr. Bochner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Allergy and Immunology, 1985 - 1988
  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1982 - 1985
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1982

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1983 - 2026
  • MD State Medical License
    MD State Medical License 1985 - 2018
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1999
  • Super Doctor SuperDoctors.com
  • Top MD Consumers Checkbook
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Scientists Say They're on Brink of Wonder Pill That Could 'Cure Most Allergies'
    Scientists Say They're on Brink of Wonder Pill That Could 'Cure Most Allergies'June 5th, 2020
  • New Pill Could Prevent Anaphylaxis in People with Food, Drug Allergies
    New Pill Could Prevent Anaphylaxis in People with Food, Drug AllergiesJune 2nd, 2020
  • Chemotherapy Drug Shows Promise in Treating Everyday Allergies
    Chemotherapy Drug Shows Promise in Treating Everyday AllergiesFebruary 20th, 2018
  • Join now to see all

Grant Support

  • Treating Lung Inflammation By Targeting SiglecsNational Heart, Lung, And Blood Institute2011
  • Basic And Clinical ImmunologyNational Institute Of Allergy And Infectious Diseases2008–2011
  • Targeting Siglec-8/Siglec-F Reduce Allergic Responses In Vitro And In VivoNational Institute Of Allergy And Infectious Diseases2007–2011
  • Determination Of Cellular And Clinical Thresholds For Ige-Mediated ReactivityNational Institute Of Allergy And Infectious Diseases2007–2010
  • Adhesion Molecule Biology In Allergic CellsNational Institute Of Allergy And Infectious Diseases2003–2007
  • Cellular And Clinical Thresholds For Ige-Mediated ReactiNational Institute Of Allergy And Infectious Diseases2006
  • Tissue-Specific Mechanisms Of Allergic InflammationNational Institute Of Allergy And Infectious Diseases2001–2004
  • Adhesion Molecule Biology In Allergic CellsNational Institute Of Allergy And Infectious Diseases2003
  • Glycolipid E-Selectin Ligands On Human GranulocytesNational Institute Of Allergy And Infectious Diseases2000–2003
  • Role Of TNF Alpha In Allergic LATE Phase ResponseNational Institute Of Allergy And Infectious Diseases2001–2002
  • Integrins And Chemokines In Allergic Cell RecruitmentNational Institute Of Allergy And Infectious Diseases1998–2002
  • Integrins And Chemokines In Allergic Cell RecruitmentNational Institute Of Allergy And Infectious Diseases1997
  • Cellular Recruitment Mechanisms In Allergic InflammationNational Heart, Lung, And Blood Institute1996–1997
  • Basophil Activation And Recruitment In Allergic DiseaseNational Institute Of Allergy And Infectious Diseases1993
  • Basophil Activation And Recruitment In Allgergic DiseaseNational Institute Of Allergy And Infectious Diseases1989–1992

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: